SCHEMBL17358243

SCHEMBL17358243

Cc1cc(OCc2ccccc2)c2c(c1)OC(c1ccc(O)c(O)c1)C(O)C2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.56
▸ BACE1 P56817 4/20 0.56
▸ HSD17B10 Q99714 4/20 0.56
▸ CYP3A4 P08684 4/20 0.56
▸ GAA P10253 3/20 0.56
▸ ALDH1A1 P00352 3/20 0.56
▸ MAPT P10636 3/20 0.56
▸ MEN1 O00255 3/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ ALOX15 P16050 3/20 0.56
▸ MAPK1 P28482 3/20 0.56
▸ PTGS1 P23219 3/20 0.56
▸ SNCA P37840 3/20 0.56
▸ PKM P14618 2/20 0.56
▸ APEX1 P27695 2/20 0.56
▸ RECQL P46063 2/20 0.56
▸ ALPL P05186 2/20 0.56
▸ POLB P06746 2/20 0.56
▸ PTGS2 P35354 2/20 0.56
▸ APP P05067 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13507916 0.91 KDM4E (0.65) KDM4EBACE1HSD17B10CYP3A4GAA
SCHEMBL16016915 0.90 CYP3A4 (0.44) KDM4EBACE1HSD17B10CYP3A4GAA
SCHEMBL15450266 0.90 CYP3A4 (0.44) KDM4EBACE1HSD17B10CYP3A4GAA
SCHEMBL15450257 0.90 CYP3A4 (0.44) KDM4EBACE1HSD17B10CYP3A4GAA
SCHEMBL15450263 0.90 CYP3A4 (0.44) KDM4EBACE1HSD17B10CYP3A4GAA
SCHEMBL31161060 0.89 KDM4E (0.57) KDM4EBACE1HSD17B10CYP3A4GAA
SCHEMBL31160643 0.89 KDM4E (0.57) KDM4EBACE1HSD17B10CYP3A4GAA
SCHEMBL17358249 0.89 CYP3A4 (0.43) KDM4EBACE1HSD17B10CYP3A4GAA
SCHEMBL17523259 0.87 CYP3A4 (0.42) KDM4EBACE1HSD17B10CYP3A4GAA
SCHEMBL17523257 0.87 CYP3A4 (0.42) KDM4EBACE1HSD17B10CYP3A4GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9556140-B2 Approach for synthesis of catechins SPHAERA PHARMA PVT. LTD. (IN) 2017-01-31 — — US disclosed
US-20150368223-A1 NOVEL APPROACH FOR SYNTHESIS OF CATECHINS EPIRIUM BIO INC. 2015-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150368223-A1 NOVEL APPROACH FOR SYNTHESIS OF CATECHINS NQO1, COMT, NNMT KDM4E 2056/4885BACE1 1434/4885HSD17B10 719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback